Alterity Therapeutics Ltd (ATHE)
followers
·
Follow
Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David A. Stamler
Employees:
10
LEVEL 3, 460 BOURKE STREET, MELBOURNE, C3, VIC 3000
61 3 9349 4906
-
Formally known as:
- Prana Biotechnology Ltd Foreign Ordinary
Date | Ratio |
---|---|
2016-03-24 | 1:6 |
2023-01-09 | 1:10 |
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's Disease.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|